The role of nitric oxide in A3 adenosine receptor-mediated cardioprotection

Autonomic and Autacoid Pharmacology

Volumn 29, Issue 3, 2009, Pages 97-104

  Hussain, A ^a   Karjian, P ^a   Maddock, H ^a  

^a Institute for Clean Growth and Future Mobility   (United Kingdom)

Author keywords

A3 adenosine receptors; Cardioprotection; Myocardial injury; Nitric oxide

Indexed keywords

ADENOSINE A3 RECEPTOR; ADENOSINE A3 RECEPTOR AGONIST; AMINOGUANIDINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLYCOGEN SYNTHASE KINASE 3BETA; INDUCIBLE NITRIC OXIDE SYNTHASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN KINASE B; RAPAMYCIN; UO 126; WORTMANNIN;

ANGINA PECTORIS; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; DRUG TARGETING; ENZYME ACTIVATION; ENZYME INHIBITION; HEART INFARCTION; HEART INFARCTION SIZE; HEART MITOCHONDRION; HEART MUSCLE CELL; HEART PROTECTION; HUMAN; ISCHEMIC HEART DISEASE; MITOCHONDRIAL MEMBRANE POTENTIAL; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANIMALS; CARDIOTONIC AGENTS; CORONARY DISEASE; FEMALE; HUMANS; MALE; MYOCARDIAL REPERFUSION INJURY; NITRIC OXIDE; RECEPTOR, ADENOSINE A3;

EID: 67651061903     PISSN: 14748665     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1474-8673.2009.00438.x     Document Type: Review

References (53)

1. BELL, R.M. YELLON, D.M. (2003a). Atorvastatin, administered at the onset ofreperfusion, and independent of lipid lowering, protects the myocardium by up regulating a prosurvival pathway. J. Am. Coll. Cardiol., 41, 508 515. (Pubitemid 36164511)
2. BOLLI, R. (2000). The late phase of preconditioning. Circ. Res., 87, 972 983. (Pubitemid 30949213)
3. BOPASSA, J.C., FERRERA, R., GATEAU-ROESCH, O., COUTURE-LEPETIT, E. OVIZE, M. (2006). PI3-kinase regulates the mitochondrial transition pore in controlled reperfusion and postconditioning. Cardiovasc. Res., 69, 178 185. (Pubitemid 41814821)
4. BUDDE, J.M., MORRIS, C.D., VELEZ, D.A., MURAKI, S., WANG, N.P., GUYTON, R.A. ZHAO, Z.Q. (2004). Reduction of infarct size and preservation of endothelial function by multidose intravenous adenosine during extended reperfusion. J. Surg. Res., 116, 104 115. (Pubitemid 38083291)
5. DATTA, S.R., DUDEK, H., TAO, X., MASTERS, S., FU, H., GOTOH, Y. GREENBERG, M.E. (1997). Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell, 91, 231 241. (Pubitemid 27456390)
6. DAVIDSON, S.M., HAUSENLOY, D., DUCHEN, M.R. YELLON, D.M. (2006). Signalling via the reperfusion injury signalling kinase (RISK) pathway links closure of the mitochondrial permeability transition pore to cardioprotection. Int. J. Biochem. Cell Biol., 38, 414 419. (Pubitemid 41821888)
7. DRURY, A.N. SZENT-GYORGYI, A. (1929). The physiological activity of adenine compounds with special reference to their action upon the mammalian heart. J. Physiol., 68, 213 237.
8. FREDHOLM, B., IJZERMAN, A., JACOBSON, K., KLOTZ, K.N. LINDEN, J. (2001). International Union of Pharmacology. XXV. Nomenclature and Classification of adenosine receptors. Pharmacol. Rev., 53, 527 552. (Pubitemid 33136237)
9. GAO, F., GAO, E., YUE, T.-L., OHLSTEIN, E.H., LOPEZ, B.L., CHRISTOPHER, T.A. MA, Y.L. (2002). Nitric oxide mediates the antiapoptotic effect of insulin in myocardial ischemia/reperfusion: The roles of PI3-kinase, Akt and endothelial nitric oxide synthase phosphorylation. Circulation, 105, 1497 1502. (Pubitemid 34263284)
10. GERMACK, R. DICKENSON, J. (2004). Characterization of ERK-1/2 signalling pathway induced by adenosine receptor subtypes in rat cardiomyocytes. Br. J. Pharmacol., 141, 329 339. (Pubitemid 38250903)
11. GERMACK, R. DICKENSON, J.M. (2005). Adenosine triggers preconditioning through MEK/ERK1/2 signalling pathway during hypoxia/reoxygenation in neonatal rat cardiomyocytes. J. Mol. Cell. Cardiol., 39, 429 442. (Pubitemid 41133729)
12. 3 adenosine receptor: an enigmatic player in cell biology. Pharmacol. Ther., 117, 123 140. (Pubitemid 350192673)
13. GROSS, E.R., PEART, J.N., HSU, A.K., GROVER, G.J. GROSS, C.J. (2003). KATP opener induced delayed cardioprotection: involvement of sarcolemmal and mitochondrial KATP channels, free radicals and MEK1/2. J. Mol. Cell. Cardiol., 35, 985 992. (Pubitemid 36871023)
14. GUO, Y., STEIN, A., WU, W.-J., ZHU, X., TAN, W., LI, Q. BOLLI, R. (2005). Late preconditioning induced by NO donors, adenosine A1 receptor agonists, and ä1-opioid receptor agonists is mediated by iNOS. Am. J. Physiol. Heart Circ. Physiol., 289, H2251 H2257.
15. HATTORI, Y., HATTORI, S. KASAI, K. (2004). Lipopolysaccharide activates Akt in vascular smooth muscle cells resulting in induction of inducible nitric oxide synthase through nuclear factor-kappa B activation. Eur. J. Pharm., 481, 153 158.
16. HAUSENLOY, D.J. YELLON, D.M. (2007). Preconditioning and postconditioning: united at reperfusion. Pharmacol. Ther., 116, 173 191. (Pubitemid 47451505)
17. HAUSENLOY, D., TSANG, A. YELLON, D. (2005). The reperfusion injury salvage kinase pathway: a common target for both ischemic preconditioning and postconditioning. Trends Cardovasc. Med., 15, 69 75. (Pubitemid 40693390)
18. HEADRICK, J.P. PEART, J. (2005). A3 adenosine receptor-mediated protection of the ischemic heart. Vasc. Pharmacol., 42, 271 279. (Pubitemid 40726330)
19. HEADRICK, J.P., HACK, B. ASHTON, K.J. (2003). Acute adenosinergic cardioprotection in the ischemic reperfused heart. Am. J. Physiol. Heart Circ. Physiol., 285, H1797 H1819.
20. HUSSAIN, A., AL-RAJAIBI, H., KARJIAN, P. MADDOCK, H.L. (2006a). Post-ischaemic administration of A3 adenosine receptor agonist ameliorates myocardial ischaemia/reperfusion injury via ERK 1-2. J. Mol. Cell Cardiol., 406, 974.
21. HUSSAIN, A., AL-RAJAIBI, H. MADDOCK, H.L. (2006b). Post ischaemic administration of A3 adenosine receptor agonist ameliorates myocardial ischaemia-reperfusion injury via PI3-kinase. Heart, 922, 014. FEB.
22. JORDAN, J.E., THOURANI, V.H., AUCHAMPACH, J.A., ROBINSON, J.A., WANG, N.P. VINTEN JOHANSEN, J. (1999). A3 adenosine receptor activation attenuates neutrophil function and neutrophil-mediated reperfusion injury. Am. J. Physiol. Heart Circ. Physiol., 277, H1895 H1905.
23. KARJIAN, P., AL-RAJAIBI, H., HUSSAIN, A. MADDOCK, H.L. (2006). Activation of A3 adenosine receptors protects the ischemic reperfused myocardium via recruitment of PI3K-AKT-iNOS cell survival pathway. Circulation, 2006, 114. II-1204.
24. KARJIAN, P., AL-RAJAIBI, H., HUSSAIN, A. MADDOCK, H.L. (2008). A3 adenosine receptor activation via 2-Cl-IBMECA protects the myocardium via recruitment of PI3K-AKT-iNOS intracellular signalling pathway during reperfusion. J. Mol. Cell. Cardiol., 44, 738.
25. KENNEDY, S.G., KANDEL, E.S., CROSS, T.K. HAY, N. (1999). Akt/protein kinase B inhibits cell death by preventing the release of cytochrome c from mitochondria. Mol. Cell Biol., 19, 5800 5810. (Pubitemid 29339934)
26. KERENDI, F., KIN, H., HALKOS, M.E., JIANG, R., ZATTA, A.J., ZHAO, Z.Q., GUYTON, R.A. VINTEN-JOHANSEN, H. (2005). Brief renal ischemia and reperfusion applied before coronary artery reperfusion reduces myocardial infarct size via endogenous activation of adenosine receptors. Basic Res. Cardiol., 100, 404 412. (Pubitemid 41300495)
27. LEE, J.E., BOKOCH, G. LIANG, B.T. (2001). A novel cardioprotective role of RhoA: new signalling mechanism for adenosine. FASEB J., 15, 1886 1894. (Pubitemid 32848792)
28. MADDOCK, H.L., BROADLEY, K.J., BRIL, A. KHANDOUDI, N. (1997). Cardioprotection from ischaemic insult in isolated working hearts by an A3 receptor agonist. Br. J. Pharmacol., 120, 19P.
29. MADDOCK, H.L., MOCANU, M. YELLON, D. (2002). Adenosine A3 receptor activation protects the myocardium from reperfusion-reoxygenation injury. Am. J. Physiol. Heart Circ. Physiol., 283, H1307 H1313.
30. MADDOCK, H.L., GARDNER, N.M., KHANDOUDI, N., BRIL, A. BROADLEY, K.J. (2003). Protection from myocardial stunning by ischaemia and hypoxia with the adenosine A3 receptor agonist, IB-MECA. Eur. J. Pharmacol., 477, 235 245. (Pubitemid 38366396)
31. NEWBY, A.C. (1984). Adenosine and the concept of retaliatory metabolites. Trends Biochem. Sci., 9, 42 44.
32. PARK, S.-S., ZHAO, H., JANG, Y., MUELLER, R. XU, Z. (2006). N6-(3-Iodobenzyl)-adenosine-5′-N-methylcarboxamide confers cardioprotection at reperfusion by inhibiting mitochondrial permeability transition pore opening via glycogensynthase kinase 3â. J. Pharmacol. Exp. Ther., 318, 124 131. (Pubitemid 43920749)
33. PARSONS, M., YOUNG, L., LEE, J.E., JACOBSON, K.A. LIANG, B.T. (2000). Distinct cardioprotective effects of adenosine mediated by differential coupling of receptor subtypes to phospholipases C and D. FASEB J., 14, 1423 1431. (Pubitemid 30439751)
34. PEART, J.N. HEADRICK, J.P. (2007). Adenosinergic cardioprotection: multiple receptors, multiple pathways. Pharmacol. Ther., 114, 208 221. (Pubitemid 46561536)
35. del PESO, L., GONZALEZ-GARCIA, M., PAGE, C., HERRERA, R. NUNEZ, G. (1997). Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science, 278, 687 689. (Pubitemid 27464966)
36. SATTIN, A. RALL, T.W. (1970). The effect of adenosine and adenine nucleotides on the cyclic adenosine 3′, 5′-phosphate content of guinea pig cerebral cortex slices. Mol. Pharmacol., 6, 13 23.
37. SCHULTE, G. FREDHOLM, B.B. (2003). Signalling from adenosine receptors to mitogen activated protein kinases. Cell. Signal., 15, 813 827. (Pubitemid 36776656)
38. SHNEYVAYS, V., JACOBSON, A., LI, A.H., NAWRATH, H., ZINMAN, T., ISAAC, A. SHAINBERG, A. (2000). Induction of apoptosis in rat cardiocytes by A3 adenosine receptor activation and its suppression by Isoproterenol. Exp. Cell Res., 257, 111 126. (Pubitemid 30324649)
39. SHNEYVAYS, V., LESHAM, D., ZINMAN, T., MAMEDOVA, L.K., JACOBSON, K.A. SHAINBERG, A. (2005). Role of adenosine A1 and A3 receptors in regulation of cardiomyocyte homeostasis after mitochondrial respiratory chain injury. Am. J. Physiol. Circ. Physiol., 288, H2792 H2801.
40. SMART, N., MOJET, M.H., LATCHMAN, D.S., MARBER, M.S., DUCHEN, M.R. HEADS, R.J. (2006). IL-6 induces PI-3-kinase and nitric oxide-dependent protection and preserves mitochondrial function in cardiomyocytes. Cardiol. Res., 69, 164 177. (Pubitemid 41814820)
41. SOMMERSCHILD, H.T. KIRKEBOEN, K.A. (2000). Adenosine and cardioprotection during ischaemia and reperfusion - an overview. Acta Anaesthesiol. Scand., 44, 1038 1055. (Pubitemid 30739959)
42. STEIN, A.B., TANG, X.L., GUO, Y., XUAN, Y.T., DAWN, B. BOLLI, R. (2004). Delayed adaption of the heart to stress: late preconditioning. Stroke, 35 (11 Suppl. 1 2676 2679. (Pubitemid 39458366)
43. TSANG, A., HAUSENLOY, D., MOCANU, M. YELLON, D. (2004). Postconditioning: a form of "modified reperfusion" protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway. Circ. Res., 95, 230 232. (Pubitemid 39056282)
44. VAN WYLEN, D.G. (1994). Effect of ischemic preconditioning on interstitial purine metabolite and lactate accumulation during myocardial ischemia. Circulation, 89, 2283 2289. (Pubitemid 24142809)
45. VINTEN-JOHANSEN, J., KIN, H. SUN, H.Y. (2003). Post-conditioning reduces myocardial injury by inhibiting reactive oxygen species during reperfusion. Circulation, 108 (Suppl. IV 219.
46. WANG, Y., KUDO, M., XU, M., AYUB, A. ASHRAF, M. (2001). Mitochondrial KATP channel as an end effector of cardioprotection during late preconditioning:triggering role of nitric oxide. J. Mol. Cell. Cardiol., 33, 2037 2046. (Pubitemid 33097281)
47. YANG, X.M., PHILIPP, S., DOWNEY, J.M. COHEN, M.V. (2005). Postconditioning's protection is not dependent on circulating blood factors or cells but involves adenosine receptors and requires PI3-kinase and guanylyl cyclase activation. Basic Res. Cardiol., 100, 57 63. (Pubitemid 40069107)
48. YELLON, D.M. BAXTER, G.F. (1999). Reperfusion injury revisited: is there a role for growth factor signalling in limiting lethal reperfusion injury? Trends Cardiovasc. Med., 9, 245 249. (Pubitemid 30947872)
49. ZHAO, T.C. KUKREJA, R.C. (2002). Late preconditioning elicited by activation of adenosine A3 receptor in heart: role of NF-kappa B, iNOS and mitochondrial KATP channel. J. Mol. Cell. Cardiol., 34, 263 277. (Pubitemid 37162420)
50. ZHAO, Z.Q., McGEE, D.S., NAKANISHI, K., TOOMBS, C.F., JOHNSON, W.E., ASHAR, M.S. VINTEN-JOHANSEN, J. (1993). Receptor mediated cardioprotective effects of endogenous adenosine are exerted primarily during reperfusion after coronary occlusion in the rabbit. Circulation, 88, 709 719. (Pubitemid 23228071)
51. ZHAO, T., XI, L., CHELLIAH, J., LEVASSEUR, E. KUKREJA, R. (2000). Inducible nitric oxide synthase mediates delayed myocardial protection induced by activation of adenosine A 1 receptors: evidence from gene-knockout mice. Circulation, 102, 902 907. (Pubitemid 30671508)
52. ZHAO, Z.Q., BUDDE, J.M., MORRIS, C., WANG, N.P., VELEZ, D.A., MURAKI, S., GUYTON, R.A. VINTEN-JOHANSEN, J. (2001). Adenosine attenuates reperfusion-induced apoptotic cell death by modulating expression of Bcl-2 and Bax proteins. J. Mol. Cell. Cardiol., 33, 57 68. (Pubitemid 32127784)
53. ZHAO, Z.Q., CORVERA, J.S., HALKOS, M.E., KERENDI, F., WANG, N.P., GUYTON, R.A. VINTEN-JOHANSEN, J. (2003a). Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am. J. Physiol. Heart Circ. Physiol., 285, H579 H588.